New Drug Candidate Shows Major Progress Against IgA Nephropathy in LateāStage Trial

A promising new medication may soon expand treatment options for people living with IgA nephropathy, a chronic autoimmune disease that damages the kidneys. Researchers recently reported encouraging results from a lateāstage clinical trial evaluating an experimental drug called povetacicept. The therapy is designed to target abnormal immune signals that drive the disease. IgA nephropathy occurs […]